Asia-Pacific markets trade mostly higher after Wall Street notches fresh record

Asia-Pacific markets trade mostly higher after Wall Street notches fresh record


Mount Fuji and the Shinjuku skyline in Tokyo, Japan, on Friday, Feb. 14, 2025. Photographer: Kiyoshi Ota/Bloomberg via Getty Images

Bloomberg | Bloomberg | Getty Images

Asia-Pacific markets traded mostly higher Friday, tracking Wall Street gains after two key benchmarks hit new records on the heels of the recent Federal Reserve decision to cut rates.

The central bank on Wednesday lowered its key overnight borrowing rate by a quarter percentage point, putting it in a range of 3.5%-3.75%.

Japan’s benchmark Nikkei 225 rose 0.96%, while the Topix added 1.18%. South Korea’s Kospi advanced 0.29%, while the small-cap Kosdaq traded around the flatline.

Australia’s benchmark S&P/ASX 200 was 0.83% higher.

Hong Kong’s Hang Seng index added 0.71%, while the mainland’s CSI 300 declined 0.2%.

China’s top leaders wrapped up an annual economic planning meeting Thursday by affirming broad economic support for the year ahead, including boosting consumption and stabilizing the property sector. Policymakers remained focused on bolstering domestic tech capabilities, a key priority for the upcoming five-year plan that kicks off in 2026.

Overnight in the U.S., the Dow Jones Industrial Average and S&P 500 reached new highs, with investors rotating out of high-flying tech stocks and into names likely to benefit from a growing U.S. economy after the Federal Reserve cut interest rates.

The 30-stock Dow rose 646.26 points, or 1.34%, to finish at 48,704.01, a fresh closing high. The index also scored a new record intraday high, supported by a rise in Visa shares after it was upgraded by Bank of America. The broad market S&P 500 traded up 0.21% to settle at 6,901.00, also a closing record. However, the Nasdaq Composite pulled back 0.26% to finish at 23,593.86.

—CNBC’s Evelyn Cheng, Sean Conlon and Pia Singh contributed to this report.



Source

Neurocrine expands into metabolic diseases with .9 billion Soleno buyout
World

Neurocrine expands into metabolic diseases with $2.9 billion Soleno buyout

Piotr Swiat | Lightrocket | Getty Images Neurocrine Biosciences will acquire rare-disease drugmaker ⁠Soleno Therapeutics for $2.9 billion in cash, the companies said on Monday, marking the neuroscience-focused ​drugmaker’s expansion into ​metabolic disorders. The deal ​gives Neurocrine access to Vykat XR, the first drug approved in the U.S. to treat hyperphagia associated with Prader-Willi syndrome, […]

Read More
JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets
World

JPMorgan CEO Jamie Dimon in annual letter cites risks in geopolitics, AI and private markets

Jamie Dimon, Chairman and CEO, JPMorganChase, speaks during the Reagan National Defense Forum at the Ronald Reagan Presidential Library in Simi Valley, California, U.S. December 6, 2025. Jonathan Alcorn | Reuters JPMorgan Chase CEO Jamie Dimon is calling for a broad recommitment to American ideals as his bank navigates geopolitical uncertainty, a teetering economy and […]

Read More
US and Iran receive peace proposal as Trump vows ‘hell’ if Strait stays shut
World

US and Iran receive peace proposal as Trump vows ‘hell’ if Strait stays shut

Smoke rises after explosions struck the northeastern, western, and central areas amid Israeli attacks in Tehran, Iran on April 1, 2026. Tolga Akbaba | Anadolu | Getty Images The United States and Iran received the framework of a plan to end hostilities, but Iran rejected immediately reopening the Strait of Hormuz, after President Donald Trump […]

Read More